Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lizeth G Meza Guzman"'
Autor:
Hao Chen, Nghi H. Nguyen, Charlene M. Magtoto, Simon A. Cobbold, Grace M. Bidgood, Lizeth G. Meza Guzman, Lachlan W. Richardson, Jason Corbin, Amanda E. Au, Bernhard C. Lechtenberg, Rebecca Feltham, Kate D. Sutherland, Christoph Grohmann, Sandra E. Nicholson, Brad E. Sleebs
Publikováno v:
Redox Biology, Vol 59, Iss , Pp 102552- (2023)
The Kelch-like ECH-associated protein 1 (KEAP1) - nuclear factor erythroid 2-related factor 2 (NRF2) signaling pathway senses reactive oxygen species and regulates cellular oxidative stress. Inhibiting KEAP1 to activate the NRF2 antioxidant response
Externí odkaz:
https://doaj.org/article/8bf601d4ee3e4a67b3cbbfafd936ded8
Autor:
Lizeth G Meza Guzman, Craig D Hyland, Grace M Bidgood, Evelyn Leong, Zihan Shen, Wilford Goh, Tobias Kratina, Jai Rautela, James E Vince, Sandra E Nicholson, Nicholas D Huntington
The clinical development of Natural Killer (NK) cell-mediated immunotherapy marks a milestone in the development of new cancer therapies and has gained traction due to the intrinsic ability of the NK cell to target and kill tumour cells. To fully har
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9288c96080d5dea0bc0340fa9048cce0
https://doi.org/10.1101/2023.04.17.537109
https://doi.org/10.1101/2023.04.17.537109
Autor:
Karen Doggett, Narelle Keating, Farhad Dehkhoda, Grace M. Bidgood, Lizeth G. Meza Guzman, Evelyn Leong, Andrew Kueh, Nicos A. Nicola, Nadia J. Kershaw, Jeffrey J. Babon, Warren S. Alexander, Sandra E. Nicholson
Publikováno v:
Cytokine. 165:156167
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35dacd35a714bc9babe6fde52ac85121
https://doi.org/10.1016/j.cyto.2023.156167
https://doi.org/10.1016/j.cyto.2023.156167
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2463
Stimulation of Natural Killer (NK) cells with cytokines, target cell interaction, or antibody mediated activation of receptors on the NK cell surface enables the dissection of specific signaling intermediates in different activation pathways. NK cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::20c9f545a9faae0d5ad0feaed052e682
https://pubmed.ncbi.nlm.nih.gov/35344175
https://pubmed.ncbi.nlm.nih.gov/35344175
Publikováno v:
Methods in Molecular Biology ISBN: 9781071621592
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c0182a8d18adfb9b4a7548ea2063f6c
https://doi.org/10.1007/978-1-0716-2160-8_13
https://doi.org/10.1007/978-1-0716-2160-8_13
Autor:
André Veillette, Indrajit Das, Sophie Krumeich, Oltin T Pop, Jason Madore, Kyohei Nakamura, Lukas Flatz, Richard A. Scolyer, Sally Pearson, Brodie Quine, Matthias Braun, Rui Li, Brett G.M. Hughes, Andreas Möller, Touraj Taheri, Maike Effern, Sunyoung Ham, Glen Kristiansen, Sandra E. Nicholson, Ailin Lepletier, Ashmitha Sundarrajan, Martin D. Batstone, Dillon Corvino, Lizeth G. Meza Guzman, Kunlun Li, Amelia Roman Aguilera, Ludovic Martinet, Elizabeth Ahern, Nazhifah Salim, Maria Villancanas Jorge, Dimo Dietrich, Luize G. Lima, Frank Vari, Ashwini Raghavendra, Mika Casey, Jennifer Landsberg, Robert J. Johnston, Gabrielle Kelly, James S. Wilmott, Mark J. Smyth, Matthias Geyer, Eun Y. Seo, Georgina V. Long, Tobias Bald, Sebastien Jacquelin, Kimberley Stannard, William C. Dougall, Lambros T. Koufariotis, Michael Hölzel
Publikováno v:
Immunity. 53:805-823.e15
The activating receptor CD226 is expressed on lymphocytes, monocytes, and platelets and promotes anti-tumor immunity in pre-clinical models. Here, we examined the role of CD226 in the function of tumor-infiltrating lymphocytes (TILs) and resistance t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0431f8cdc19691e62922cc7c53ff6c85
https://doi.org/10.1016/j.immuni.2020.09.010
https://doi.org/10.1016/j.immuni.2020.09.010
Publikováno v:
Cancers, Vol 12, Iss 952, p 952 (2020)
Cancers
Cancers
Natural killer (NK) cells play a pivotal role in cancer immunotherapy due to their innate ability to detect and kill tumorigenic cells. The decision to kill is determined by the expression of a myriad of activating and inhibitory receptors on the NK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::315a4d3b1e5266b9c9b6a2a1958e4bec
https://doi.org/10.3390/cancers12040952
https://doi.org/10.3390/cancers12040952